RECENT NEWS
PreciseDx secures funding to advance AI-powered breast cancer risk assessments
PreciseDx, a leading innovator in oncology diagnostics leveraging artificial intelligence (AI) for new, morphology-driven disease analysis, has announced that it has raised $20.7 million in Series B funding, bringing its total funding to date to $31.5 million.
Introducing Amplify Rigid PCR plates
Alpha Laboratories has launched its new Amplify Rigid PCR plates, designed to set a new standard in laboratory efficiency and reliability. These innovative plates feature a rugged polycarbonate frame, providing a solid and flat surface that ensures seamless interaction with automated liquid handling platforms.
Roche working to enhance mpox testing
Roche has said that it is supporting the international response to the mpox global health emergency with its diagnostic tests developed for mpox, formerly known as monkeypox.
Paige introduces OmniScreen AI tool
Digital pathology and AI firm Paige has announed the launch of OmniScreen, a pioneering AI-driven biomarker module capable of evaluating over 505 genes and detecting 1,228 molecular biomarkers from routine H&E-stained digital pathology slides.
Register now for Lab Innovations 2024
Visitor registration for Lab Innovations 2024 is now live. The UK’s largest annual exhibition for the whole laboratory industry will take place at the NEC, Birmingham, on 30-31 October, featuring engaging talks and exhibitors that will showcase innovation and champion sustainability.
Synnovis restores testing services
Pathology services provider Synnovis has recently confirmed it has rebuilt its core IT systems following the cyberattack on 3 June. It has now resumed testing services for GPs in Bexley, Lewisham and Greenwich, three of the six boroughs it serves.
New study shows difficulty of diagnosing Long COVID
A new study has found that most routine laboratory tests are not reliable for diagnosing Long COVID, also known as Post-Acute Sequelae of SARS-CoV-2 infection (PASC).
WHO declares mpox outbreak a public health emergency
WHO Director-General Dr Tedros Adhanom Ghebreyesus has determined that the upsurge of mpox in the Democratic Republic of the Congo (DRC) and a growing number of countries in Africa constitutes a public health emergency of international concern (PHEIC) under the International Health Regulations.
RCPath submits evidence to NHS review
The Royal College of Pathologists (RCPath) has submitted evidence to Lord Darzi's review of the NHS outlining the challenges and opportunities facing pathology services.
Strategic partnership to revolutionise urine testing
Alpha Laboratories has entered into a strategic partnership with Clinical Design Technologies to market and support that company's digital closed urine testing system. This innovative technology offers unmatched clinical efficacy, simplicity, and accuracy, setting a new standard for urinalysis at the point of care.
Roche finalises acquisition of LumiraDx’s POC technology
Roche has recently announced the completion of the acquisition of LumiraDx’s point-of-care technology, following the receipt of all required antitrust and regulatory clearances. Roche will now embark on the full integration of the company’s innovative multi-assay point of care platform and the related R&D, operational and commercial sites into its global organisation.
Breakthrough in studying deadly ventilator pneumonia
Scientists at the University of Warwick have made a breakthrough which could help find new treatments for a deadly infection that can affect up to 40% of hospital patients using mechanical ventilators.
UKHSA warns of rising antibiotic resistant gonorrhoea cases
New data from the UK Health Security Agency (UKHSA) highlights a rise in antibiotic-resistant gonorrhoea infections in England.
The August issue of Pathology in Practice is now available to read
The latest issue of Pathology in Practice is now available to read online.
£28.5m in funding for Human Functional Genomics Initiative
The Medical Research Council (MRC), in collaboration with the Biotechnology and Biological Sciences Research Council (BBSRC), has provided £28.5 million in funding to establish the Human Functional Genomics Initiative programme. It aims to advance our understanding of how genomic variation influences human physiology and how it changes over time and in disease.
Stago UK introduces novel platelet-retrieving device
Stago UK is introducing a unique autotransfusion system, able to preserve functional platelets as well as red blood cells. It offers a safer alternative to scarce, risky and expensive blood transfusion products. Stago UK has partnered with i-SEP, one of France’s most innovative MedTech companies, to distribute its novel ‘same’ system.
Paige launches second generation of Virchow AI foundation model
Paige, a global leader in clinical AI applications for cancer, in collaboration with Microsoft, has unveiled the second generation of Virchow, its million-slide foundation model for cancer.
Beckman Coulter Life Sciences and Illumina accelerate oncology research
Beckman Coulter Life Sciences, in partnership with Illumina, a leader in DNA sequencing and array-based technologies, offers a promising new approach to oncology research delivering faster results with fewer touchpoints. The Illumina TruSight Oncology 500 DNA/RNA assay on the Biomek NGeniuS System from Beckman Coulter Life Sciences provides an automated solution enabling comprehensive genomic profiling of tumour samples.
MIP Discovery rebrands as Tozaro to focus on CGT bioprocessing
MIP Discovery has announced the company’s rebrand to Tozaro, completing its transition to becoming a technology innovator in the cell and gene therapy (CGT) bioprocessing sector.
Aiforia to provide AI solutions for cancer diagnostics for Fimlab Laboratories
Fimlab Laboratories has selected Aiforia Technologies as the provider for breast and prostate cancer diagnostics solutions. Fimlab is Finland’s largest healthcare laboratory company, owned by the wellbeing services counties of Pirkanmaa, Central Finland, Kanta-Häme, Ostrobothnia, and Päijät-Häme.
Latest Issues
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
11th Digital Pathology & AI Congress: Europe
Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024
Microbiology Society Annual Conference 2025
Liverpool Arena and Convention Centre
31 March - 3 April, 2025
BSMT Annual Microbiology Conference
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Ghent Pathology 2025
ICC Ghent, Belgium
24-26 June, 2025
37th European Congress of Pathology
ACV, Vienna, Austria
6 -10 September, 2025